Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Core Laboratories N.V. (CLB : NYSE)
 
 • Company Description   
Core Laboratories N.V. is a leading provider of proprietary and patented Reservoir Description and Production Enhancement services. Core Laboratories' reservoir optimization technologies are used to increase total recovery from existing fields. Core Laboratories' services enable clients to optimize reservoir performance and maximize hydrocarbon recovery from their producing fields. Core Laboratories has taken extensive measures to ensure the services and data provided by all of worldwide companies are of the highest quality and integrity. Core Laboratories' commitment to applying and developing new technologies to optimize reservoir performance is unsurpassed in the oilfield service industry. This commitment to technology and to your bottom line makes Core Laboratories, The Reservoir Optimization Company.

Number of Employees: 3,700

 
 • Price / Volume Information   
Yesterday's Closing Price: $24.47 Daily Weekly Monthly
20 Day Moving Average: 510,225 shares
Shares Outstanding: 46.31 (millions)
Market Capitalization: $1,133.15 (millions)
Beta: 2.71
52 Week High: $49.87
52 Week Low: $21.08
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -24.08% -17.14%
12 Week -6.50% -1.56%
Year To Date 9.68% 27.85%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
VAN HEUVEN GOEDHARTLAAN 7 B 1181 LE
-
AMSTELVEEN,P7 1077 XX
NLD
ph: 31-20-420-3191
fax: -
investor.relations@corelab.com http://www.corelab.com
 
 • General Corporate Information   
Officers
Lawrence Bruno - Chief Executive Officer; Chairman;President
Christopher S. Hill - Senior Vice President and Chief Financial Officer
Kevin G. Daniels - Vice President; Treasurer
Gregory B. Barnett - Director
Martha Z. Carnes - Director

Peer Information
Core Laboratories N.V. (BJS)
Core Laboratories N.V. (CXIPY)
Core Laboratories N.V. (ALY)
Core Laboratories N.V. (HLX)
Core Laboratories N.V. (CNCJQ)
Core Laboratories N.V. (FGHLQ)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: OIL-FIELD SVCS
Sector: Oils/Energy
CUSIP: N22717107
SIC: 1389
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/27/22
Share - Related Items
Shares Outstanding: 46.31
Most Recent Split Date: 7.00 (2.00:1)
Beta: 2.71
Market Capitalization: $1,133.15 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.16%
Current Fiscal Quarter EPS Consensus Estimate: $0.14 Indicated Annual Dividend: $0.04
Current Fiscal Year EPS Consensus Estimate: $0.68 Payout Ratio: 0.06
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: -0.59
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 05/06/2022 - $0.01
Next EPS Report Date: 07/27/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 35.88
Trailing 12 Months: 38.23
PEG Ratio: -
Price Ratios
Price/Book: 6.81
Price/Cash Flow: 21.87
Price / Sales: 2.37
EPS Growth
vs. Year Ago Period: -46.67%
vs. Previous Quarter: -60.00%
Sales Growth
vs. Year Ago Period: 6.38%
vs. Previous Quarter: -7.86%
ROE
03/31/22 - 18.28
12/31/21 - 21.03
09/30/21 - 23.49
ROA
03/31/22 - 5.00
12/31/21 - 5.57
09/30/21 - 5.40
Current Ratio
03/31/22 - 2.03
12/31/21 - 2.08
09/30/21 - 2.01
Quick Ratio
03/31/22 - 1.54
12/31/21 - 1.58
09/30/21 - 1.54
Operating Margin
03/31/22 - 6.16
12/31/21 - 6.96
09/30/21 - 6.87
Net Margin
03/31/22 - 2.04
12/31/21 - 4.20
09/30/21 - 6.66
Pre-Tax Margin
03/31/22 - 4.78
12/31/21 - 7.68
09/30/21 - 9.80
Book Value
03/31/22 - 3.59
12/31/21 - 3.48
09/30/21 - 3.48
Inventory Turnover
03/31/22 - 8.62
12/31/21 - 8.78
09/30/21 - 8.96
Debt-to-Equity
03/31/22 - 1.14
12/31/21 - 1.17
09/30/21 - 1.17
Debt-to-Capital
03/31/22 - 53.29
12/31/21 - 53.95
09/30/21 - 53.93
 

Powered by Zacks Investment Research ©